自己注射用デバイスの世界市場2020-2026:再利用可能自己注射器、使い捨て自己注射器

QYResearchが発行した調査報告書(QYR20AP11095)
◆英語タイトル:Global Self Injection Device Industry Research Report, Growth Trends and Competitive Analysis 2020-2026
◆商品コード:QYR20AP11095
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年3月(※2024年版があります。お問い合わせください。)
◆ページ数:116
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD5,600 ⇒換算¥828,800見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD8,400 ⇒換算¥1,243,200見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD11,200 ⇒換算¥1,657,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

当リサーチレポートでは、自己注射用デバイスの世界市場規模が2019年xx百万ドルから2026年xx百万ドルまで年平均xx%成長すると予測しています。当レポートは、自己注射用デバイスのグローバル市場動向、主要メーカー別の市場シェア、種類別市場規模(再利用可能自己注射器、使い捨て自己注射器)、用途別市場規模(インスリン注射、エピネフリン注射、その他)、地域別(北米、ヨーロッパ、中国、日本)生産規模、地域別(北米、ヨーロッパ、アジア、中南米、中東・アフリカ)消費規模、バリューチェーン、販売チャネル、市場機会・課題・市場環境分析、関連企業情報などを掲載しています。

・レポート概要
・グローバル市場動向
・メーカー別市場シェア
・自己注射用デバイスの種類別市場予測2015-2026:再利用可能自己注射器、使い捨て自己注射器
・自己注射用デバイスの用途別市場予測2015-2026:インスリン注射、エピネフリン注射、その他
・自己注射用デバイスの地域別生産規模2015-2026:北米、ヨーロッパ、中国、日本
・自己注射用デバイスの地域別消費規模2015-2026:北米、ヨーロッパ、アジア、中南米、中東・アフリカ
・関連企業情報:Novo Nordisk、Mylan、Pfizer、Sanofi、BD、Eli Lilly、Gerresheimer、Dongbao、Ypsomed、Owen Mumford、Antares Pharma、Haselmeier
・自己注射用デバイスの地域別生産規模予測2021-2026:北米、ヨーロッパ、中国、日本
・自己注射用デバイスの地域別消費規模予測2021-2026:北米、ヨーロッパ、アジア、中南米、中東・アフリカ
・バリューチェーン及び販売チャネル分析
・市場機会・課題・市場環境分析
・結論
【レポートの概要】

The injectors were initially designed to overcome the hesitation associated with self-administration of the needle-based drug delivery device.
An auto-injector is a medical device designed to deliver a dose of a particular drug.
The global average price of Self-Injection Device is in the increasing trend, from 14.4 USD/Unit in 2012 to 15.2 USD/Unit in 2016. With the situation of global economy, prices will be in decreasing trend in the following five years.
The Self Injection Device market was valued at US$ 8015.2 Million in 2019 and is projected to reach US$ 12110 Million by 2026, at a CAGR of 6.0% during the forecast period. In this study, 2019 has been considered as the base year and 2020 to 2026 as the forecast period to estimate the market size for Self Injection Device.

In terms of production side, this report researches the Self Injection Device capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.
In terms of consumption side, this report focuses on the consumption of Self Injection Device by regions (countries) and application.
The global Self Injection Device market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Self Injection Device market. These figures have been provided in terms of both revenue and volume for the period 2015-2026. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise and country-wise Self Injection Device markets such as the U.S., Canada, Germany, France, the U.K., Italy, Russia, China, Japan, South Korea, Taiwan, India, the Philippines, Malaysia, Thailand, Indonesia, Vietnam Australia, Mexico, Brazil, Saudi Arabia, the UAE and Turkey etc. Key regions covered in the report are North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.
For the period 2015-2026, the report provides country-wise revenue and production capacity analysis and region-wise revenue and volume analysis of the global Self Injection Device market. For the period 2015-2020, it provides consumption (consumption) analysis and forecast of different regional markets by Application as well as by Type in terms of volume.
Market Segmentation
The report includes a detailed analysis of leading and by Type and by Application segments of the global Self Injection Device market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers value, volume analysis and forecast of the global Self Injection Device market by Type and by Application segment for the period 2015-2026.
Segment by Type, the Self Injection Device market is segmented into
Reusable Self Injection Device
Disposable Self Injection Device

Segment by Application, the Self Injection Device market is segmented into
Insulin Injection
Epinephrine Injection
Other
Competitive Landscape and Self Injection Device Market Share Analysis
Self Injection Device market competitive landscape provides details and data information by manufacturers. The report offers comprehensive analysis and accurate statistics on production capacity, revenue and price by the player for the period 2015-2020. Details included are company description, major businesses, company total revenue and the production capacity, revenue generated in Self Injection Device business, competitors, the date to enter into the Self Injection Device market, Self Injection Device product introduction, recent developments, etc.

The major vendors covered:
Novo Nordisk
Mylan
Pfizer
Sanofi
BD
Eli Lilly
Gerresheimer
Dongbao
Ypsomed
Owen Mumford
Antares Pharma
Haselmeier

The study objectives are:
To analyze and research the global Self Injection Device status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Self Injection Device manufacturers, capacity, production, revenue, market share, and recent development.
To split the breakdown data by regions, type, manufacturers and application.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Self Injection Device are as follows:
History Year: 2015-2020
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Top Self Injection Device Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Self Injection Device Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 Reusable Self Injection Device
1.3.3 Disposable Self Injection Device
1.4 Market Segment by Application
1.4.1 Global Self Injection Device Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 Insulin Injection
1.4.3 Epinephrine Injection
1.4.4 Other
1.5 Study Objectives
1.6 Years Considered

2 Global Market Perspective
2.1 Global Self Injection Device Production Capacity Analysis
2.1.1 Global Self Injection Device Production Value (2015-2026)
2.1.2 Global Self Injection Device Production (2015-2026)
2.1.3 Global Self Injection Device Capacity (2015-2026)
2.1.4 Global Self Injection Device Marketing Pricing and Trends
2.2 Global Self Injection Device Market Size Growth Potential by Key Producing Regions
2.2.1 Global Self Injection Device Market Size by Key Producing Regions: 2015 VS 2021 VS 2026
2.2.2 Global Self Injection Device Market Share by Key Producing Regions: 2021 VS 2026
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Primary Interviews with Key Self Injection Device Players: Views for Future

3 Market Share by Manufacturers
3.1 Global Top Manufacturers by Self Injection Device Production Capacity
3.1.1 Global Top Manufacturers by Self Injection Device Production Capacity (2015-2020)
3.1.2 Global Top Manufacturers by Self Injection Device Production (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Self Injection Device Production in 2019
3.2 Global Top Manufacturers by Self Injection Device Revenue
3.2.1 Global Top Manufacturers by Self Injection Device Revenue (2015-2020)
3.2.2 Global Top Manufacturers Market Share by Self Injection Device Revenue (2015-2020)
3.2.3 Global Self Injection Device Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Self Injection Device as of 2019)
3.4 Global Self Injection Device Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Self Injection Device Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Self Injection Device Market
3.7 Key Manufacturers Self Injection Device Product Offered
3.8 Mergers & Acquisitions, Expansion Plans

4 Estimate and Forecast by Type (2015-2026)
4.1 Global Self Injection Device Historic Market Size by Type (2015-2020)
4.1.2 Global Self Injection Device Production Market Share by Type (2015-2020)
4.1.3 Global Self Injection Device Production Value Market Share by Type
4.1.4 Self Injection Device Average Selling Price (ASP) by Type (2015-2020)
4.2 Global Self Injection Device Market Size Forecast by Type (2021-2026)
4.2.2 Global Self Injection Device Production Market Share Forecast by Type (2021-2026)
4.2.3 Global Self Injection Device Production Value Market Share Forecast by Type
4.2.4 Self Injection Device Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Self Injection Device Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Self Injection Device Consumption by Application (2015-2020)
5.2 Global Self Injection Device Consumption by Application (2021-2026)

6 Production by Regions: Market Fact & Figures
6.1 Global Self Injection Device Production (History Data) by Regions (2015-2020)
6.2 Global Self Injection Device Production Value (History Data) by Regions
6.3 North America
6.3.1 North America Self Injection Device Production Growth Rate (2015-2020)
6.3.2 North America Self Injection Device Production Value Growth Rate (2015-2020)
6.3.3 Key Players Market Share in North America
6.3.4 North America Self Injection Device Import & Export (2015-2020)
6.4 Europe
6.4.1 Europe Self Injection Device Production Growth Rate (2015-2020)
6.4.2 Europe Self Injection Device Production Value Growth Rate (2015-2020)
6.4.3 Key Players Market Share in Europe
6.4.4 Europe Self Injection Device Import & Export (2015-2020)
6.5 China
6.5.1 China Self Injection Device Production Growth Rate (2015-2020)
6.5.2 China Self Injection Device Production Value Growth Rate (2015-2020)
6.5.3 Key Players Market Share in China
6.5.4 China Self Injection Device Import & Export (2015-2020)
6.6 Japan
6.6.1 Japan Self Injection Device Production Growth Rate (2015-2020)
6.6.2 Japan Self Injection Device Production Value Growth Rate (2015-2020)
6.6.3 Key Players Market Share in Japan
6.6.4 Japan Self Injection Device Import & Export (2015-2020)

7 Self Injection Device Consumption by Regions: Market Fact & Figures
7.1 Global Self Injection Device Consumption (History Data) by Regions (2015-2020)
7.2 Global Top Self Injection Device Consumers (regions/countries) Ranking and Share of Total Self Injection Device Consumption in 2015 VS 2019
7.3 North America
7.3.1 North America Self Injection Device Consumption by Type
7.3.2 North America Self Injection Device Consumption by Application
7.3.3 North America Self Injection Device Consumption by Countries
7.3.4 U.S.
7.3.5 Canada
7.4 Europe
7.4.1 Europe Self Injection Device Consumption by Type
7.4.2 Europe Self Injection Device Consumption by Application
7.4.3 Europe Self Injection Device Consumption by Countries
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
7.5 Asia Pacific
7.5.1 Asia Pacific Self Injection Device Consumption by Type
7.5.2 Asia Pacific Self Injection Device Consumption by Application
7.5.3 Asia Pacific Self Injection Device Consumption by Regions
7.5.4 China
7.5.5 Japan
7.5.6 South Korea
7.5.7 India
7.5.8 Australia
7.5.9 Taiwan
7.5.10 Indonesia
7.5.11 Thailand
7.5.12 Malaysia
7.5.13 Philippines
7.5.14 Vietnam
7.6 Central & South America
7.6.1 Central & South America Self Injection Device Consumption by Type
7.6.2 Central & South America Self Injection Device Consumption by Application
7.6.3 Central & South America Self Injection Device Consumption by Countries
7.6.4 Mexico
7.6.5 Brazil
7.6.6 Argentina
7.7 Middle East and Africa
7.7.1 Middle East and Africa Self Injection Device Consumption by Type
7.7.2 Middle East and Africa Self Injection Device Consumption by Application
7.7.3 Central & South America Self Injection Device Consumption by Countries
7.7.4 Turkey
7.7.5 Saudi Arabia
7.7.6 U.A.E

8 Company Profiles
8.1 Novo Nordisk
8.1.1 Novo Nordisk Corporation Information
8.1.2 Novo Nordisk Business Overview and Total Revenue (2019 VS 2018)
8.1.3 Novo Nordisk Self Injection Device Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
8.1.4 Self Injection Device Products and Services
8.1.5 Novo Nordisk SWOT Analysis
8.1.6 Novo Nordisk Recent Developments
8.2 Mylan
8.2.1 Mylan Corporation Information
8.2.2 Mylan Business Overview and Total Revenue (2019 VS 2018)
8.2.3 Mylan Self Injection Device Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
8.2.4 Self Injection Device Products and Services
8.2.5 Mylan SWOT Analysis
8.2.6 Mylan Recent Developments
8.3 Pfizer
8.3.1 Pfizer Corporation Information
8.3.2 Pfizer Business Overview and Total Revenue (2019 VS 2018)
8.3.3 Pfizer Self Injection Device Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
8.3.4 Self Injection Device Products and Services
8.3.5 Pfizer SWOT Analysis
8.3.6 Pfizer Recent Developments
8.4 Sanofi
8.4.1 Sanofi Corporation Information
8.4.2 Sanofi Business Overview and Total Revenue (2019 VS 2018)
8.4.3 Sanofi Self Injection Device Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
8.4.4 Self Injection Device Products and Services
8.4.5 Sanofi SWOT Analysis
8.4.6 Sanofi Recent Developments
8.5 BD
8.5.1 BD Corporation Information
8.5.2 BD Business Overview and Total Revenue (2019 VS 2018)
8.5.3 BD Self Injection Device Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
8.5.4 Self Injection Device Products and Services
8.5.5 BD SWOT Analysis
8.5.6 BD Recent Developments
8.6 Eli Lilly
8.6.1 Eli Lilly Corporation Information
8.6.3 Eli Lilly Self Injection Device Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
8.6.3 Eli Lilly Self Injection Device Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
8.6.4 Self Injection Device Products and Services
8.6.5 Eli Lilly SWOT Analysis
8.6.6 Eli Lilly Recent Developments
8.7 Gerresheimer
8.7.1 Gerresheimer Corporation Information
8.7.2 Gerresheimer Business Overview and Total Revenue (2019 VS 2018)
8.7.3 Gerresheimer Self Injection Device Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
8.7.4 Self Injection Device Products and Services
8.7.5 Gerresheimer SWOT Analysis
8.7.6 Gerresheimer Recent Developments
8.8 Dongbao
8.8.1 Dongbao Corporation Information
8.8.2 Dongbao Business Overview and Total Revenue (2019 VS 2018)
8.8.3 Dongbao Self Injection Device Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
8.8.4 Self Injection Device Products and Services
8.8.5 Dongbao SWOT Analysis
8.8.6 Dongbao Recent Developments
8.9 Ypsomed
8.9.1 Ypsomed Corporation Information
8.9.2 Ypsomed Business Overview and Total Revenue (2019 VS 2018)
8.9.3 Ypsomed Self Injection Device Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
8.9.4 Self Injection Device Products and Services
8.9.5 Ypsomed SWOT Analysis
8.9.6 Ypsomed Recent Developments
8.10 Owen Mumford
8.10.1 Owen Mumford Corporation Information
8.10.2 Owen Mumford Business Overview and Total Revenue (2019 VS 2018)
8.10.3 Owen Mumford Self Injection Device Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
8.10.4 Self Injection Device Products and Services
8.10.5 Owen Mumford SWOT Analysis
8.10.6 Owen Mumford Recent Developments
8.11 Antares Pharma
8.11.1 Antares Pharma Corporation Information
8.11.2 Antares Pharma Business Overview and Total Revenue (2019 VS 2018)
8.11.3 Antares Pharma Self Injection Device Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
8.11.4 Self Injection Device Products and Services
8.11.5 Antares Pharma SWOT Analysis
8.11.6 Antares Pharma Recent Developments
8.12 Haselmeier
8.12.1 Haselmeier Corporation Information
8.12.2 Haselmeier Business Overview and Total Revenue (2019 VS 2018)
8.12.3 Haselmeier Self Injection Device Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
8.12.4 Self Injection Device Products and Services
8.12.5 Haselmeier SWOT Analysis
8.12.6 Haselmeier Recent Developments

9 Self Injection Device Production Side by Producing Regions (Countries)
9.1 Global Self Injection Device Production Value Forecast by Region (2021-2026)
9.2 Self Injection Device Production Forecast by Regions
9.3 Key Self Injection Device Producing Regions Forecast
9.3.1 North America
9.3.2 Europe
9.3.3 China
9.3.4 Japan

10 Self Injection Device Consumption Forecast by Top Consumers (Regions/Countries)
10.1 Global Self Injection Device Consumption Forecast by Region (2021-2026)
10.2 North America Market Consumption YoY Growth Forecast
10.2.1 North America Self Injection Device Consumption YoY Growth (2021-2026)
10.2.2 North America Self Injection Device Consumption Forecast by Country (2021-2026)
10.3 Europe Market Consumption YoY Growth Forecast
10.3.1 Europe Self Injection Device Consumption YoY Growth (2021-2026)
10.3.2 Europe Self Injection Device Consumption Forecast by Country (2021-2026)
10.4 Asia Pacific Market Consumption YoY Growth Forecast
10.4.1 Asia Pacific Self Injection Device Consumption YoY Growth (2021-2026)
10.4.1 Asia Pacific Self Injection Device Consumption Forecast by Regions (2021-2026)
10.5 Latin America Market Consumption YoY Growth Forecast
10.5.1 Latin America Self Injection Device Consumption YoY Growth (2021-2026)
10.5.2 Latin America Self Injection Device Consumption Forecast by Country (2021-2026)
10.6 Middle East and Africa Market Consumption YoY Growth Forecast
10.6.1 Middle East and Africa Self Injection Device Consumption YoY Growth (2021-2026)
10.6.2 Middle East and Africa Self Injection Device Consumption Forecast by Country (2021-2026)

11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Self Injection Device Sales Channels
11.2.2 Self Injection Device Distributors
11.3 Self Injection Device Customers

12 Opportunities & Challenges, Threat and Affecting Factors
12.1 Market Opportunities
12.2 Market Challenges
12.3 Porter’s Five Forces Analysis

13 Key Findings

14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

...

【掲載企業】

Novo Nordisk、Mylan、Pfizer、Sanofi、BD、Eli Lilly、Gerresheimer、Dongbao、Ypsomed、Owen Mumford、Antares Pharma、Haselmeier

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 自己注射用デバイスの世界市場2020-2026:再利用可能自己注射器、使い捨て自己注射器(Global Self Injection Device Industry Research Report, Growth Trends and Competitive Analysis 2020-2026)]についてメールでお問い合わせはこちらでお願いします。